Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ryffel

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Renal Physiology and Biochemistry|May 1, 1995
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphataseQ Su, L Weber, M Le Hir, et al.
Progress in Allergy|January 1, 1986
Experimental autoimmunityR B Nussenblatt, H C Gunn, B Ryffel, et al.
Biochemical and Biophysical Research Communications|August 16, 1993
Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin AB Ryffel, G Woerly, M Murray, et al.
Transplantation|August 1, 1988
Syngeneic graft-versus-host disease induced by cyclosporine--a reappraisalL H Chow, L Mosbach-Ozmen, B Ryffel, et al.
European Journal of Biochemistry|June 1, 1995
Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin BQ Su, M Zhao, E Weber, et al.
Transplantation Proceedings|February 1, 1989
A comparison of cyclosporine binding by cyclophilin and calmodulinB M Foxwell, W C Wong, J F Borel, et al.
Ultrastructural Pathology|January 1, 1987
Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine AJ Fasel, B Kaissling, K S Ludwig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathwaysL G Bekker, S Freeman, P J Murray, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Journal of Interferon Research|October 1, 1994
Soluble interferon-gamma receptor: a therapeutically useful drug for systemic lupus erythematosusL Ozmen, D Roman, M Fountoulakis, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Renal Physiology and Biochemistry|May 1, 1995
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphataseQ Su, L Weber, M Le Hir, et al.
Progress in Allergy|January 1, 1986
Experimental autoimmunityR B Nussenblatt, H C Gunn, B Ryffel, et al.
Biochemical and Biophysical Research Communications|August 16, 1993
Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin AB Ryffel, G Woerly, M Murray, et al.
Transplantation|August 1, 1988
Syngeneic graft-versus-host disease induced by cyclosporine--a reappraisalL H Chow, L Mosbach-Ozmen, B Ryffel, et al.
European Journal of Biochemistry|June 1, 1995
Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin BQ Su, M Zhao, E Weber, et al.
Transplantation Proceedings|February 1, 1989
A comparison of cyclosporine binding by cyclophilin and calmodulinB M Foxwell, W C Wong, J F Borel, et al.
Ultrastructural Pathology|January 1, 1987
Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine AJ Fasel, B Kaissling, K S Ludwig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathwaysL G Bekker, S Freeman, P J Murray, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Journal of Interferon Research|October 1, 1994
Soluble interferon-gamma receptor: a therapeutically useful drug for systemic lupus erythematosusL Ozmen, D Roman, M Fountoulakis, et al.
Pageof 20